Autoimmune Myasthenia, Primary Adrenal Insufficiency, and Progressive Hypothyroidism Due to Pembrolizumab and Axitinib Combination Regimen

Immune checkpoint inhibitors (ICI) and tyrosine kinase inhibitors (TKI) have been among the increasingly used antineoplastic agents for advanced cancers including renal cell carcinoma (RCC). Although these antineoplastic agents have broad range of efficacy, rare adverse events - mild and fatal, acut...

Descripción completa

Detalles Bibliográficos
Autores principales: Figueroa-Perez, Nikole, Kashyap, Rahul, Bal, Deepinder, Anjum Khan, Syed, Pattan, Vishwanath
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2021
Materias:
Endocrinology/Diabetes/Metabolism
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8412885/
https://www.ncbi.nlm.nih.gov/pubmed/34513503
http://dx.doi.org/10.7759/cureus.16933

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8412885/
https://www.ncbi.nlm.nih.gov/pubmed/34513503
http://dx.doi.org/10.7759/cureus.16933

Ejemplares similares